Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Model of Epigenetic Biomarkers Based on cfDNA 5mC/5hmC for Early Detection of Colorectal Cancer

NCT07224854 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT07224854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07224854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Model of Epigenetic Biomarkers Based on cfDNA 5mC/5hmC for Early Detection of Colorectal Cancer
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Active, not recruiting
Start date
June 21, 2024
Completion date
June 18, 2028
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cell free dna, colorectal cancer (diagnosis), dna methylation, early detection of cancer, non-cancer controls